C07D 219/04
Heterocyclic compounds containing acridine or hydrogenated acridine ring systems: with hetero atoms
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
C07D219/04 (Heterocyclic compounds containing acridine or hydrogenated acridine ring systems: with hetero atoms) appears on 467 US grants and 328 published applications in this corpus.
Search patents in C07D- Granted patents
- 467
- Published applications
- 328
- Assignees
- 302
- Inventors
- 1,136
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 11 | 0 |
| 1978 | 5 | 0 |
| 1979 | 6 | 0 |
| 1980 | 0 | 0 |
| 1981 | 5 | 0 |
| 1982 | 5 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 8 | 0 |
| 1987 | 8 | 0 |
| 1988 | 2 | 0 |
| 1989 | 11 | 0 |
| 1990 | 4 | 0 |
| 1991 | 7 | 0 |
| 1992 | 8 | 0 |
| 1993 | 14 | 0 |
| 1994 | 16 | 0 |
| 1995 | 14 | 0 |
| 1996 | 11 | 0 |
| 1997 | 17 | 0 |
| 1998 | 19 | 0 |
| 1999 | 8 | 0 |
| 2000 | 18 | 0 |
| 2001 | 18 | 9 |
| 2002 | 12 | 21 |
| 2003 | 18 | 14 |
| 2004 | 10 | 22 |
| 2005 | 8 | 19 |
| 2006 | 5 | 9 |
| 2007 | 17 | 7 |
| 2008 | 5 | 12 |
| 2009 | 4 | 13 |
| 2010 | 10 | 17 |
| 2011 | 7 | 8 |
| 2012 | 9 | 11 |
| 2013 | 5 | 14 |
| 2014 | 12 | 17 |
| 2015 | 21 | 8 |
| 2016 | 9 | 20 |
| 2017 | 9 | 7 |
| 2018 | 6 | 18 |
| 2019 | 10 | 11 |
| 2020 | 9 | 14 |
| 2021 | 6 | 12 |
| 2022 | 12 | 15 |
| 2023 | 5 | 8 |
| 2024 | 12 | 7 |
| 2025 | 8 | 11 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions for treating cancer22 Sep 2026US 12,740,976 B2City of Hope
- Polymerizable absorbers of UV and high energy visible light12 May 2026US 12,624,214 B2Johnson & Johnson Vision Care, Inc.
- Tetradentate ligands, gold(III) complexes, preparation method and use thereof2 Dec 2025US 12,490,645 B2
- Bisaminoquinolines and bisaminoacridines compounds and methods of their use1 Jul 2025US 12,343,339 B2The Trustees of the University of Pennsylvania
- Small molecule inhibition of sulfotransferase SULT1A36 May 2025US 12,291,504 B2Albert Einstein College of Medicine
- Polymerizable absorbers of uv and high energy visible light6 Aug 2026US 2026/0226278 A1Johnson & Johnson Vision Care, Inc.
- Pannexin-1 modulators and methods of treating disorders in which pannexin-1 is implicated28 May 2026US 2026/0146041 A1Pannex Therapeutics Inc.
- Papd5 inhibitors and methods of use thereof30 Apr 2026US 2026/0115182 A1Children's Medical Center Corporation
- Tetrahydroacridinone analogues for treatment and prevention of malaria9 Apr 2026US 2026/0098012 A1Northeastern University
- Novel ras inhibitors27 Nov 2025US 2025/0360124 A1
Most cited
By later US patents
- Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences267US 5,658,737 AGen-Probe Incorporated · 1997
- Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods234US 5,414,077 AGilead Sciences, Inc. · 1995
- Chromogenic acridinone enzyme substrates137US 4,810,636 AMiles Inc. · 1989
- Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles105US 5,667,764 AZynaxis, Inc. · 1997
- Nucleophilic polysubstituted aryl acridinium esters and uses thereof85US 5,241,070 ACiba Corning Diagnostics Corp. · 1993